Arca
Skip to content
Tools
Tools

Xerostomia

Drug research and approvals for xerostomia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 73 studies of xerostomia are recruiting on ClinicalTrials.gov, Health Canada has authorized 4 drug trials for it since 2013, and FDA has 3 approved and 3 open orphan designations naming it.

  • Recruiting worldwide: 73
  • Trials authorized in Canada: 4
  • FDA orphan approvals: 3
  • EU medicines: 0

Recruiting now

Newest posted first, of 73 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 3

  • PilocarpineMuscarinic acetylcholine receptor M3 agonist
  • CevimelineMuscarinic acetylcholine receptor M3 agonist
  • AmifostineReactive metabolite scavenging agent

Phase 3 6

Phase 2 2

Phase 1 or earlier 3

How its trials ended

225 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 35 whose ending is known, 51% met their primary endpoint, 6% missed it and 43% stopped early.

  • Completed, result not reported11752%
  • Ongoing4520%
  • Status unknown2812%
  • Met its primary endpoint188%
  • Stopped: other or unclear84%
  • Stopped: enrollment or feasibility31%
  • Missed its primary endpoint21%
  • Stopped: funding21%
  • Stopped: lack of efficacy1<1%
  • Stopped: sponsor or business decision1<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Feb 3, 2026Pretherapy botulinum toxin to reduce radiation-related xerostomia in head and neck cancerBotoxResearch Institute of The McGill University Health CentrePending
Mar 7, 2025Long-term follow-up of AAV2-HAQP1 gene therapy in participants with radiation-induced late xerostomiaAAV2-HAQP1MeiraGTx HoldingsOngoing
Sep 29, 2023A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of AAV2-HAQP1 gene therapy in participants with radiation-induced…AAV2-HAQP1MeiraGTx HoldingsOngoing
Feb 28, 2020"a phase 1/2 open-label, dose escalation study to determine the optimal dose, safety, and efficiacy of AAV2HAQP1 in subjects with radiation-induced parotid…AAV2HAQP1MeiraGTx HoldingsPending

FDA orphan designations

Approved first, then open designations, newest first
Jun 24, 1999EthyolReduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck…Medimmune Oncology, Inc.Approved
Feb 11, 1998SalagenTreatment of dry mouth in patients with Sjogren's syndrome.MGI Pharma, Inc.Approved
Mar 22, 1994SalagenTreatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.MGI Pharma, Inc.Approved
May 3, 2013Replication-deficient recombinant serotype 2…Treatment of symptoms of Grade 2 and Grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral…MeiraGTx, LLCDesignated
Jul 31, 2001Intraoral fluoride releasing systemPrevention of dental caries due to radiation-induced xerostomia in patients with head and neck cancerDigestive Care, Inc.Designated
Dec 20, 1999Recombinant human keratinocyte growth factorReducing the incidence and severity of radiation-induced xerostomia.Swedish Orphan Biovitrum AB (publ) (SOBI)Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.